Adverse-drug-reaction related admissions to a hospital in Scotland

被引:0
|
作者
Yvonne Hopf
Margaret Watson
David Williams
机构
[1] Aberdeen Royal Infirmary,Department of Pharmacy
[2] University of Aberdeen,Department of General Practice and Primary Care
[3] Aberdeen Royal Infirmary,Department of Clinical Pharmacology
来源
Pharmacy World & Science | 2008年 / 30卷
关键词
Adverse drug reaction; Hospital admission; Non-prescription drug; OTC medicines; Prescription medicines; Scotland;
D O I
暂无
中图分类号
学科分类号
摘要
Aims To apply established methods to identify ADR-related admissions and to determine the proportion which was preventable and which were caused by non-prescription medicines (NPMs). Methods This prospective, observational study screened all acute hospital admissions (n = 1,101) by ward pharmacists over a 2-week period. Suspected ADR-related admissions were reported to the researcher and established criteria were used to evaluate probability, causality and preventability of the ADR-related admissions. Results Of the 1,101 emergency admissions which occurred during the study period, 30 were categorised as ADR-related, equating to a prevalence of 2.7% (95% CI, 1.8–3.7%). Three (9.7%) of the 30 admissions were associated with NPMs. The ADR was the dominant reason for admission in 56.7% (n = 17/30) and only 13.3% (n = 4/30) of all reported admissions were assessed as unavoidable. Conclusion The proportion of ADR-related admissions was lower than in previous studies in the UK. A substantial proportion of ADRs was associated with NPMs, highlighting the need for greater awareness amongst patients, prescribers and other health care professionals regarding possible serious adverse effects caused by these medicines.
引用
收藏
相关论文
共 50 条
  • [1] Adverse-drug-reaction related admissions to a hospital in Scotland
    Hopf, Yvonne
    Watson, Margaret
    Williams, David
    [J]. PHARMACY WORLD & SCIENCE, 2008, 30 (06): : 854 - 862
  • [2] ADVERSE-DRUG-REACTION MONITORING
    FAICH, GA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (24): : 1589 - 1592
  • [3] Adverse-drug-reaction reporting by pharmacy students in a teaching hospital
    Sullivan, Karyn M.
    Spooner, Linda M.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (12) : 1177 - 1179
  • [4] A STUDY ON ADVERSE DRUG REACTION RELATED HOSPITAL ADMISSIONS OF A TERTIARY CARE HOSPITAL IN SOUTH INDIA
    Kuruvilla, A.
    [J]. VALUE IN HEALTH, 2021, 24 : S92 - S92
  • [5] Improving adverse-drug-reaction reporting in ambulatory care clinics at a Veterans Affairs hospital
    Aspinall, MB
    Whittle, J
    Aspinall, SL
    Maher, RL
    Good, CB
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (09) : 841 - 845
  • [6] THE PREVALENCE AND CHARACTERISTICS OF ADVERSE DRUG REACTION-RELATED HOSPITAL ADMISSIONS IN OLDER PATIENTS
    Cahir, C. C.
    Curran, C. C.
    Walsh, C. W.
    Williams, D. W.
    Bennett, K. B.
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2020, 74 : A36 - A37
  • [7] Prevalence and characteristics of adverse drug reaction-related hospital admissions in older Patients
    Cahir, Caitriona
    Curran, Carmel
    Walsh, Caroline
    Williams, David J.
    Bennett, Kathleen
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 213 - 213
  • [8] Drug-drug interactions and the risk of adverse drug reaction-related hospital admissions in the older population
    Hughes, John E.
    Moriarty, Frank
    Bennett, Kathleen E.
    Cahir, Caitriona
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (04) : 959 - 975
  • [9] Medication Regimen Complexity Index Prediction of Adverse Drug Reaction-Related Hospital Admissions
    Curtain, Colin M.
    Chang, Jie Yi
    Cousins, Justin
    Parameswaran Nair, Nibu
    Bereznicki, Bonnie
    Bereznicki, Luke
    [J]. ANNALS OF PHARMACOTHERAPY, 2020, 54 (10) : 996 - 1000
  • [10] Sex differences in hospital admissions related to adverse drug reactions
    Hendriksen, Linda C.
    van der Linden, Paul D.
    Herings, Ron M. C.
    Stricker, Bruno H.
    Visser, Loes E.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 601 - 602